XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Entity Wide Disclosures
9 Months Ended
Sep. 30, 2023
Entity Wide Disclosures [Abstract]  
Entity Wide Disclosures Entity Wide Disclosures
Revenue by Category
The following table disaggregates our revenue by major source (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Therapeutic Area
Oncology$149,326 $122,834 $438,366 $343,589 
Other106,160 72,767 294,319 216,739 
Metabolic103,118 63,478 277,818 167,194 
Cardiology44,360 49,802 142,107 129,225 
Central Nervous System43,989 43,418 120,412 120,811 
AVAI45,546 31,445 114,419 88,340 
Total revenue$492,499 $383,744 $1,387,441 $1,065,898